Trial NCT04521621

View at ClinicalTrials.gov 
Org. Study IDs: V937-013
Secondary IDs: 2020-001908-42 V937-013 jRCT2033200191

Last trial update was posted on 2024-03-22

MeSH Interventions

Pembrolizumab

MeSH Conditions

Neoplasm Metastasis

Other Conditions


Stopping Reasons

Business Reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID